| | AstraZeneca is increasing stockpiles of those medicines in Britain and Europe that could be affected by Brexit by around 20 percent, in preparation for potential disruption if the UK crashes out of the EU without a deal. | |
| Complacency is starting to stall the fight against the global AIDS epidemic, with the pace of progress not matching what is needed, the United Nations warned on Wednesday. | |
| A low-budget Chinese movie about a leukemia patient who turns to smuggling cheaper cancer drugs from India has struck a chord with Internet users and even the country's leaders, spotlighting national anxieties about unaffordable hospital care. | |
| Smiths Group Plc expects a 2 percent drop in full-year revenue at its medical unit, hurt by some products losing certifications under a new regulation and the loss of two contracts in the United States, it said on Wednesday. | |
| (Reuters Health) - Adolescents who have harmed themselves or tried to commit suicide may be less likely to do it again when they participate in an intense therapy program focused on both individual and family treatment, a U.S. study suggests. | |
| (Reuters Health) - Teens who spend lots of time surfing the web, playing games and chatting with friends on smartphones and tablets may be more likely to develop ADHD symptoms than youth who don’t, a U.S. study suggests. | |
| (Reuters Health) - The kind of imaging U.S. women receive after treatment for non-metastatic breast cancer can vary widely, a new study finds. | |
| (Reuters Health) - The 46 medicines given approval through 2017 as part of the U.S. Food and Drug Administration's Breakthrough Therapy program have often been sent to patients without a large double-blind study, direct measurement of benefit, or comparison with a placebo or existing treatment, according to a new analysis by researchers at Yale University and the Yale School of Medicine. | |
| A common blood pressure and heart drug manufactured in bulk by a Chinese company and sold worldwide may have contained an impurity linked to cancer since 2012, European regulators said on Tuesday. | |
| Billionaire Bill Gates and Estée Lauder Cos chairman emeritus Leonard Lauder on Tuesday said they will award $30 million over three years to encourage development of new tests for early detection of Alzheimer's disease. | |
| Johnson & Johnson on Tuesday reported better-than-expected second quarter profit as sales of pharmaceuticals surged 20 percent despite a sharp decline in blockbuster arthritis drug Remicade, and its shares rose more than 4 percent. | |
|
| |